Poverty, Health, and Nutrition Division, International Food Policy Research Institute, Washington, DC.
Department of Health Promotion, Education, and Behavior, University of South Carolina, Columbia, SC.
Adv Nutr. 2019 Mar 1;10(2):196-204. doi: 10.1093/advances/nmy101.
The past decade has seen an unprecedented increase in attention to undernutrition, and drastically reducing child stunting has become a global development objective. The strong focus on linear growth retardation and stunting has enabled successful advocacy for nutrition, but with this focus has come some confusion and misunderstanding about the meaning of linear growth retardation and stunting among researchers, donors, and agencies active in nutrition. Motivated by the belief that a sharp focus will further accelerate progress in reducing undernutrition, we critically reviewed the evidence. The global attention to stunting is based on the premise that any intervention aimed at improving linear growth will subsequently lead to improvements in the correlates of linear growth retardation and stunting. Current evidence and understanding of mechanisms does not support this causal thinking, with 2 exceptions: linear growth retardation is a cause of difficult births and poor birth outcomes. Linear growth retardation is associated with (but does not cause) delayed child development, reduced earnings in adulthood, and chronic diseases. We thus propose distinguishing 2 distinctly different meanings of linear growth retardation and stunting. First, the association between linear growth retardation (or stunting) and other outcomes makes it a useful marker. Second, the causal links with difficult births and poor birth outcomes make linear growth retardation and stunting outcomes of intrinsic value. In many cases a focus on linear growth retardation and stunting is not necessary to improve the well-being of children; in many other cases, it is not sufficient to reach that goal; and for some outcomes, promoting linear growth is not the most cost-efficient strategy. We appeal to donors, program planners, and researchers to be specific in selecting nutrition outcomes and to target those outcomes directly.
过去十年,人们对营养不良的关注度空前提高,大幅降低儿童发育迟缓率已成为全球发展目标。人们强烈关注线性生长迟缓与发育迟缓,这为营养领域的宣传工作提供了助力,但与此同时,研究人员、捐赠者和营养机构对线性生长迟缓与发育迟缓的含义也产生了一些混淆和误解。鉴于我们坚信精准聚焦将进一步加速减少营养不良工作的推进,我们对现有证据进行了批判性评估。全球对发育迟缓的关注基于以下前提,即任何旨在改善线性生长的干预措施随后都将导致与线性生长迟缓相关的指标得到改善。但目前的证据和对机制的理解并不支持这种因果思维,仅有两个例外:线性生长迟缓是难产和不良分娩结局的一个原因。线性生长迟缓与儿童发育迟缓、成年后收入减少和慢性病相关(但不会导致这些问题)。因此,我们建议区分线性生长迟缓与发育迟缓的两种截然不同的含义。首先,线性生长迟缓(或发育迟缓)与其他结果之间的关联使其成为一个有用的标志物。其次,与难产和不良分娩结局的因果关系使线性生长迟缓与发育迟缓成为具有内在价值的结果。在许多情况下,关注线性生长迟缓与发育迟缓对于改善儿童福祉并非必要;在许多其他情况下,这还远远不够;对于某些结果而言,促进线性生长并非最具成本效益的策略。我们呼吁捐赠者、规划人员和研究人员在选择营养结果时要明确具体,并直接针对这些结果开展工作。